Abstract
Background Due to the imminent growth of the world population, shortage of protein sources for human consumption will arise in the near future. Alternative and sustainable protein sources (e.g. insects and algae) are now being explored for the production of food and feed. In this project the safety of mealworm (Tenebrio molitor L.) proteins for human consumption was tested according to the European Food Safety Authority (EFSA) [1] guidelines for allergenicity risk assessment of genetically modified organisms (GMO). Methods Different mealworm protein fractions (soluble and insoluble) were prepared, characterized, and tested for cross-reactivity using IgE from patients with an inhalation or food allergy to closely related species (house dust mite and crustacean) according to the phylogenetic tree, using immunoblotting and indirect basophil activation. Furthermore, the stability was investigated using an in vitro pepsin digestion test. Results IgE from both house dust mite and crustacean allergic patients cross-reacted with proteins in mealworm. This cross-reactivity was functional, as shown by the induction of basophil activation. The cross-reactive proteins were identified as tropomyosin and arginine kinase, which are well known allergens in lobster, shrimp and house dust mite. These proteins were mildly stable in the pepsin stability test. Conclusion
Highlights
Due to the imminent growth of the world population, shortage of protein sources for human consumption will arise in the near future
House dust mite (Derp 10) and crustacean allergic patients may be at risk when consuming food containing mealworm proteins
Alternative and sustainable protein sources are being explored for the production of food and feed. In this project the safety of mealworm (Tenebrio molitor L.) proteins for human consumption was tested according to the European Food Safety Authority (EFSA) [1] guidelines for allergenicity risk assessment of genetically modified organisms (GMO)
Summary
House dust mite (Derp 10) and crustacean allergic patients may be at risk when consuming food containing mealworm proteins. KC Verhoeckx1,2,3*, S van Broekhoven, M Gaspari, SC de Hartog-Jager, G de Jong, H Wichers, E van Hoffen, G Houben, AC Knulst. From Food Allergy and Anaphylaxis Meeting (FAAM 2013) Nice, France. From Food Allergy and Anaphylaxis Meeting (FAAM 2013) Nice, France. 7-9 February 2013
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.